Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 3 Device Recallsee related information
Date Initiated by FirmJune 13, 2003
Date PostedAugust 20, 2003
Recall Status1 Terminated 3 on November 01, 2004
Recall NumberZ-1138-03
Recall Event ID 26892
Product Classification Analyzer, Chemistry (Photometric, Discrete), For Clinical Use - Product Code JJE
ProductImmulite 2000. Immunoassay system. Software version 2.6 was to be uploaded on systems running 2.5b software.
Code Information All units.
FEI Number 1000122204
Recalling Firm/
Manufacturer		 DPC Cirrus
62 Flanders-Bartley Road
Flanders NJ 07836
For Additional Information ContactAlicia Salerno
973-927-2828 Ext. 4521
Manufacturer Reason
for Recall		Version 2.6 software was released however it will not properly handle adjustment slopes.
FDA Determined
Cause 2		Other
ActionRecall Technical Bulletins were sent out on 6/13/2003 to all Immulite 2000 users instructing them to not install the provided version 2.6 software.
Quantity in Commerce434 upgrades
DistributionSoftware was distributed to Immulite 2000 users throughout the nation. These units are found in hospitals and clinics. Software was also distributed to the firm''s service representatives.
Total Product Life CycleTPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
-
-